[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:interstitial-lung-disease":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":309,"states":310},"Interstitial Lung Disease",59,47,[8,16,23,29,35,41,47,53,59,66,72,78,84,90,96,102,108,113,119,126,132,138,143,149,155,161,167,173,179,186,191,197,203,209,215,221,226,232,238,244,250,255,261,267,273,279,285,290,297,303],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06325696","H01 in Adults With Interstitial Lung Disease (The SOLIS Study)",[12],"Phase 2","RECRUITING","2026-08-26T02:19:28.327680Z","2026-07-30T01:46:14.464030Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07285655","A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD",[20],"Phase 3","2026-08-26T02:19:05.360997Z","2026-07-05T05:32:16.673139Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07333183","A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD",[12],"2026-08-26T02:16:16.995720Z","2026-05-05T02:43:29.696914Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT07179380","Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)",[20],"2026-08-26T02:18:35.425468Z","2026-05-05T02:43:29.642504Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT06195072","Platform Clinical Study for Conquering Scleroderma",[12],"2026-08-26T02:17:53.433613Z","2026-05-05T02:43:29.069843Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT06806592","A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases",[20],"2026-08-26T02:15:18.897219Z","2026-05-05T02:43:28.956069Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT07323732","A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease",[12],"2026-08-26T02:17:30.961790Z","2026-05-05T02:43:27.755967Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT07486869","Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study",[12],"2026-08-26T02:16:16.169331Z","2026-05-05T02:43:27.250331Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":64,"content_modified":65},"NCT07372989","Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease",[63],"Phase 1","2026-08-26T02:17:48.768272Z","2026-05-05T02:43:27.072193Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT07473700","Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease",[12],"2026-08-26T02:15:36.077529Z","2026-05-05T02:43:26.957167Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT05943535","Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)",[20],"2026-08-26T02:18:11.042248Z","2026-05-05T02:43:26.897073Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT05120934","Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough",[12],"2026-08-26T02:18:52.966503Z","2026-05-05T02:35:31.808304Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT05892614","Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)",[12],"2026-08-26T02:17:39.857430Z","2026-05-05T02:35:31.671761Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT06576271","A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants",[63],"2026-08-26T02:18:13.438956Z","2026-07-05T05:32:16.765412Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT06716606","A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)",[20],"2026-08-26T02:16:38.897933Z","2026-05-05T02:43:29.473028Z",{"nct_id":103,"title":104,"phases":105,"status":13,"updated_at":106,"content_modified":107},"NCT07201922","A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis",[20],"2026-08-26T02:16:54.876240Z","2026-05-05T02:43:28.793339Z",{"nct_id":109,"title":110,"phases":111,"status":13,"updated_at":27,"content_modified":112},"NCT07047690","A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis",[12],"2026-05-05T02:43:28.619268Z",{"nct_id":114,"title":115,"phases":116,"status":13,"updated_at":117,"content_modified":118},"NCT03630211","Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis",[12],"2026-08-26T02:15:53.461103Z","2026-05-05T02:43:28.295890Z",{"nct_id":120,"title":121,"phases":122,"status":13,"updated_at":124,"content_modified":125},"NCT05746039","Feasibility of Semaglutide in Advanced Lung Disease",[123],"Phase 1\u002FPhase 2","2026-08-26T02:15:51.395565Z","2026-05-05T02:43:27.598354Z",{"nct_id":127,"title":128,"phases":129,"status":13,"updated_at":130,"content_modified":131},"NCT07175038","A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)",[12],"2026-08-26T02:15:21.365312Z","2026-05-05T02:43:27.062073Z",{"nct_id":133,"title":134,"phases":135,"status":13,"updated_at":136,"content_modified":137},"NCT06572384","A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease",[20],"2026-08-26T02:18:02.701182Z","2026-05-05T02:43:28.672548Z",{"nct_id":139,"title":140,"phases":141,"status":13,"updated_at":57,"content_modified":142},"NCT07572383","Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis",[12],"2026-05-13T02:55:06.735398Z",{"nct_id":144,"title":145,"phases":146,"status":13,"updated_at":147,"content_modified":148},"NCT06911632","Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension",[],"2026-08-26T02:18:07.037408Z","2026-05-13T02:55:06.591188Z",{"nct_id":150,"title":151,"phases":152,"status":13,"updated_at":153,"content_modified":154},"NCT01280994","Hyperpolarized 129Xe MRI for Imaging Pulmonary Function",[12],"2026-08-26T02:19:17.380174Z","2026-05-05T02:43:29.215955Z",{"nct_id":156,"title":157,"phases":158,"status":13,"updated_at":159,"content_modified":160},"NCT05417776","Collagen-targeted PET Imaging for Early Interstitial Lung Disease",[12],"2026-08-26T02:18:12.612955Z","2026-05-05T02:43:28.335557Z",{"nct_id":162,"title":163,"phases":164,"status":13,"updated_at":165,"content_modified":166},"NCT07613099","Evaluation of Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74 PET\u002FCT Imaging)",[20],"2026-08-26T02:18:00.873391Z","2026-05-29T15:36:40.234557Z",{"nct_id":168,"title":169,"phases":170,"status":13,"updated_at":171,"content_modified":172},"NCT04624490","Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease",[63],"2026-08-26T02:19:19.162260Z","2026-05-05T02:43:29.714235Z",{"nct_id":174,"title":175,"phases":176,"status":13,"updated_at":177,"content_modified":178},"NCT03535545","Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients",[63],"2026-08-26T02:16:05.813655Z","2026-05-05T02:43:28.403580Z",{"nct_id":180,"title":181,"phases":182,"status":13,"updated_at":184,"content_modified":185},"NCT05365802","FAPI PET for Lung Fibrosis",[183],"Early Phase 1","2026-08-03T02:04:08.415522Z","2026-05-05T02:43:27.183218Z",{"nct_id":187,"title":188,"phases":189,"status":13,"updated_at":94,"content_modified":190},"NCT06038630","129Xe MRI Cardiopulmonary",[12],"2026-04-29T02:57:57.153418Z",{"nct_id":192,"title":193,"phases":194,"status":13,"updated_at":195,"content_modified":196},"NCT07704567","MoblO2 to Maintain Oxygenation",[],"2026-08-26T02:15:09.079045Z","2026-07-19T19:36:05.084965Z",{"nct_id":198,"title":199,"phases":200,"status":13,"updated_at":201,"content_modified":202},"NCT06162884","Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis",[],"2026-08-26T02:18:51.833592Z","2026-07-05T05:32:16.745648Z",{"nct_id":204,"title":205,"phases":206,"status":13,"updated_at":207,"content_modified":208},"NCT06129240","An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH",[],"2026-08-26T02:16:34.792807Z","2026-07-05T03:45:20.246991Z",{"nct_id":210,"title":211,"phases":212,"status":13,"updated_at":213,"content_modified":214},"NCT07512687","Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia",[],"2026-08-26T02:16:48.735701Z","2026-06-14T18:39:22.245226Z",{"nct_id":216,"title":217,"phases":218,"status":13,"updated_at":219,"content_modified":220},"NCT06855329","PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis",[],"2026-08-26T02:18:39.640967Z","2026-05-13T02:55:06.584853Z",{"nct_id":222,"title":223,"phases":224,"status":13,"updated_at":106,"content_modified":225},"NCT06388421","DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)",[],"2026-05-13T02:55:06.486376Z",{"nct_id":227,"title":228,"phases":229,"status":13,"updated_at":230,"content_modified":231},"NCT06397677","Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease",[],"2026-08-26T02:17:41.695983Z","2026-05-13T02:55:06.486328Z",{"nct_id":233,"title":234,"phases":235,"status":13,"updated_at":236,"content_modified":237},"NCT03478826","Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)",[],"2026-08-26T02:16:56.877406Z","2026-05-13T02:55:06.125859Z",{"nct_id":239,"title":240,"phases":241,"status":13,"updated_at":242,"content_modified":243},"NCT01915511","Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry",[],"2026-08-26T02:19:10.436356Z","2026-05-13T02:55:06.079810Z",{"nct_id":245,"title":246,"phases":247,"status":13,"updated_at":248,"content_modified":249},"NCT00258583","Dorothy P. and Richard P. Simmons Center for ILD Research Registry",[],"2026-08-26T02:17:09.131534Z","2026-05-13T02:55:06.032938Z",{"nct_id":251,"title":252,"phases":253,"status":13,"updated_at":230,"content_modified":254},"NCT05382572","Pulmonary Fibrosis Foundation Community Registry",[],"2026-05-13T02:55:06.302948Z",{"nct_id":256,"title":257,"phases":258,"status":13,"updated_at":259,"content_modified":260},"NCT04664192","Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research",[],"2026-08-03T02:35:33.342592Z","2026-05-13T02:55:06.258421Z",{"nct_id":262,"title":263,"phases":264,"status":13,"updated_at":265,"content_modified":266},"NCT00470327","A Study of the Natural Progression of Interstitial Lung Disease (ILD)",[],"2026-08-26T02:16:22.235886Z","2026-05-13T02:55:06.035938Z",{"nct_id":268,"title":269,"phases":270,"status":13,"updated_at":271,"content_modified":272},"NCT05798923","LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)",[12],"2026-08-26T02:15:38.131683Z","2026-07-19T19:36:05.138939Z",{"nct_id":274,"title":275,"phases":276,"status":13,"updated_at":277,"content_modified":278},"NCT05854563","Cough Capture as a Portal Into the Lung",[],"2026-08-26T02:19:04.543908Z","2026-05-13T02:55:06.389497Z",{"nct_id":280,"title":281,"phases":282,"status":13,"updated_at":283,"content_modified":284},"NCT05392881","Interstitial Lung Disease Research Unit Biobank",[],"2026-08-26T02:18:46.948970Z","2026-05-13T02:55:06.304070Z",{"nct_id":286,"title":287,"phases":288,"status":13,"updated_at":33,"content_modified":289},"NCT07269262","SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers",[],"2026-05-05T02:43:28.338941Z",{"nct_id":291,"title":292,"phases":293,"status":294,"updated_at":295,"content_modified":296},"NCT07222592","MOBoxy: MoblO2 to Maintain Oxygenation",[],"NOT_YET_RECRUITING","2026-08-26T02:15:48.613507Z","2026-05-05T02:43:28.222622Z",{"nct_id":298,"title":299,"phases":300,"status":294,"updated_at":301,"content_modified":302},"NCT07613216","A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension",[],"2026-08-26T02:16:36.513735Z","2026-05-29T15:36:40.232556Z",{"nct_id":304,"title":305,"phases":306,"status":294,"updated_at":307,"content_modified":308},"NCT07673237","Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring",[],"2026-08-26T02:15:03.757872Z","2026-07-05T03:45:20.433669Z",[],[311,315,319,322,326,329,333,336,339,343,347,350,353,357,360,364,367,370,374,378,381,384,388,391],{"state":312,"count":313,"slug":314},"California",22,"california",{"state":316,"count":317,"slug":318},"Florida",19,"florida",{"state":320,"count":317,"slug":321},"New York","new-york",{"state":323,"count":324,"slug":325},"Pennsylvania",18,"pennsylvania",{"state":327,"count":324,"slug":328},"Texas","texas",{"state":330,"count":331,"slug":332},"Arizona",15,"arizona",{"state":334,"count":331,"slug":335},"Colorado","colorado",{"state":337,"count":331,"slug":338},"Massachusetts","massachusetts",{"state":340,"count":341,"slug":342},"North Carolina",14,"north-carolina",{"state":344,"count":345,"slug":346},"Kansas",13,"kansas",{"state":348,"count":345,"slug":349},"Michigan","michigan",{"state":351,"count":345,"slug":352},"Ohio","ohio",{"state":354,"count":355,"slug":356},"Illinois",12,"illinois",{"state":358,"count":355,"slug":359},"Virginia","virginia",{"state":361,"count":362,"slug":363},"Minnesota",11,"minnesota",{"state":365,"count":362,"slug":366},"South Carolina","south-carolina",{"state":368,"count":362,"slug":369},"Utah","utah",{"state":371,"count":372,"slug":373},"Oregon",9,"oregon",{"state":375,"count":376,"slug":377},"Alabama",8,"alabama",{"state":379,"count":376,"slug":380},"Missouri","missouri",{"state":382,"count":376,"slug":383},"Tennessee","tennessee",{"state":385,"count":386,"slug":387},"Georgia",7,"georgia",{"state":389,"count":386,"slug":390},"Louisiana","louisiana",{"state":392,"count":386,"slug":393},"Maryland","maryland"]